法醫學基因組分析市場－全球產業規模、佔有率、趨勢、機會和預測：按組件、技術、應用、地區和競爭格局分類，2021-2031年

全球法醫學基因組分析市場預計將從 2025 年的 6.0255 億美元成長到 2031 年的 14.3943 億美元，複合年成長率為 15.62%。

在這一領域，基因組分析工具被應用於法醫學和刑事調查中，利用從犯罪現場證據和屍體上採集的DNA來準確識別個體。市場擴張的主要驅動力是全球犯罪率的上升，促使人們需要更先進的DNA分析和鑑定技術。此外，DNA分析工具的不斷發展以及各國政府為建立和擴展國家DNA資料庫所做的努力也顯著刺激了市場需求。例如，根據美國司法部的報告，到2024年，CODIS資料庫將建立超過2,000萬個犯罪檔案，並協助偵破超過60萬起案件。儘管存在這些積極因素，但尖端基因組技術所需的大量資金投入仍然是市場成長的主要障礙。先進設備、專用試劑和複雜的生物資訊軟體的高昂成本對許多法醫學實驗室，特別是發展中地區的實驗室來說，是一個嚴重的限制因素，導致市場接受度和實用化速度放緩。

市場促進因素

DNA分析和基因組學技術的進步是全球法醫學基因組學分析市場的核心驅動力。定序系統、生物資訊學和DNA圖譜分析的持續創新，使得法醫學機構能夠以更高的準確性和靈敏度處理微量或劣化的DNA等具有挑戰性的檢體。這些技術飛躍也促進了法醫學遺傳譜系學等先進技術的應用，從而拓展了對以往未解之謎的調查範圍。據WLRN報道，總部位於德克薩斯州的Othram公司在2026年4月報告稱，其技術已幫助全美至少偵破了600起懸案。這些進步對於確定親緣關係、識別屍體以及將嫌疑人與犯罪現場聯繫起來至關重要，最終將加強全球執法機關。同時，政府對法醫科學的支持和資金投入不斷增加，在建立市場基礎設施​​和擴大營運規模方面發揮關鍵作用。世界各地的執法機構日益認知到先進DNA檢測在公共安全和破案方面的重要性，這促使他們增加對專業培訓、技術整合和資料庫擴展的直接投資。這些措施的主要目標是減少未破的法醫學案件數量，並改善複雜案件的調查工具。例如，2026年4月，WLRN報道稱，佛羅裡達州總檢察長宣布與一家專注於將未破案件中的DNA與基因系譜網路連接起來的公司建立價值60萬美元的合作關係。這筆資金將用於採購基因組分析硬體和建立全球夥伴關係。此外，2025年12月，Othram強調了這些投資推動的法醫學基因組分析的廣泛益處，該公司透過全面的重新調查，成功識別了北美477具身份不明的屍體。

市場挑戰

尖端基因組學技術所需的巨額資金投入是全球法醫學基因組學分析市場成長的主要障礙。這項障礙包括購買複雜的生物資訊軟體、專用試劑和先進設備等現代DNA檢測所需設備的高成本。如此沉重的經濟負擔對許多法醫學機構而言都是一個巨大的挑戰，尤其是那些預算有限或位於開發中國家。因此，這些高昂的初始成本直接阻礙了現代基因組學分析技術的廣泛應用和實用化。面臨資金限制的機構往往難以購買必要的設備，也難以支付軟體授權和日常耗材等持續營運成本。這種困境限制了它們採用新的基因組學分析技術和升級現有系統的能力，最終阻礙了整個市場的發展。例如，法醫科學聯盟（CFSO）在其2024年7月發布的2025會計年度預算摘要中指出，美國眾議院提案將撥給國家失踪和身份不明人員系統（NamUs）的600萬美元中至少200萬美元用於高密度定序。這項資金限制凸顯了許多地區面臨的預算困境，並直接影響法醫學和刑事調查中精準基因組資源的廣泛應用。

市場趨勢

次世代定序（NGS）技術在常規犯罪調查中的廣泛應用，從根本上改變了法醫實驗室的辦案成果。這一轉變使得對典型刑事案件進行更全面、更精細的基因評估成為可能，超越了以往低解析度技術的限制。 NGS能夠同時分析數量遠超過以往的基因標記，即使是難以分析或微量DNA證據，也能提供更深入的調查資訊。例如，雪城大學在2025年6月發表的題為《設定標準，保障正義》的報告中指出，可汗地區刑事研究所有效地利用NGS技術，對一起謀殺案的證據樣本中的150多個基因標記進行了評估。這代表著一項重大進步，因為傳統方法只能辨識出約24個標記。同時，結合人工智慧（AI）和生物資訊學的自動化數據分析正成為一種顯著趨勢，幫助實驗室應對日益成長且日益複雜的基因組資訊。人工智慧工具簡化了複雜的數據分析工作流程，提高了DNA混合物分離的準確性，並最大限度地降低了解碼複雜圖譜時人為錯誤的風險。這種自動化對於提高實驗室效率和加快案件解決速度至關重要。為了凸顯這一轉變，Research.com 在 2026 年 4 月發表的報導《人工智慧、自動化與 2026 年法醫學位職業的未來》中指出，美國 35% 的法醫機構已經開始將基於人工智慧的技術融入日常營運中。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球法醫學基因體分析市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依組件（試劑盒、分析儀/定序儀、軟體、耗材）
  • 依技術（毛細管電泳{CE}、次世代定序{NGS}、PCR擴增）
  • 透過應用（刑事調查、親子鑑定/家庭關係鑑定、生物學辯護等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美法醫學基因體分析市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲法醫學基因體分析市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區法醫學基因體分析市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲法醫學基因組分析市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲法醫學基因體分析市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球法醫學基因體分析市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Illumina, Inc.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Thermo Fischer Scientific, Inc.
• QIAGEN NV
• GE Healthcare
• Gene by Gene, Ltd.
• Neogen Corporation
• Eurofins Scientific SE
• Othram Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Forensic Genomics Market is expected to expand from USD 602.55 million in 2025 to USD 1439.43 million by 2031, reflecting a compound annual growth rate (CAGR) of 15.62%. This field utilizes genomic tools in legal and criminal inquiries to accurately identify individuals using DNA from crime scene evidence or human remains. Market expansion is largely fueled by rising global crime rates that necessitate sophisticated DNA profiling and identification methods. Additionally, the continuous evolution of DNA analysis tools and government efforts to create or enlarge national DNA databases heavily stimulate market demand. For example, the U.S. Department of Justice reported that by 2024, the CODIS database had produced over 20 million offender profiles, assisting in more than 600,000 cases. Even with these positive factors, the high financial investment needed for cutting-edge genomic technologies poses a major obstacle to market growth. The steep expenses tied to advanced machinery, specialized reagents, and intricate bioinformatics software act as a severe constraint for many forensic labs, especially in developing areas, which ultimately slows down wider market adoption and practical application.

Market Driver

Progress in DNA analysis and genomic technologies acts as a central catalyst propelling the global forensic genomics market forward. Ongoing breakthroughs in sequencing systems, bioinformatics, and DNA profiling allow forensic facilities to handle difficult samples, such as trace or degraded DNA, with heightened precision and sensitivity. These technological leaps also promote the use of sophisticated techniques like forensic genetic genealogy, broadening the investigative scope for previously unsolvable mysteries. As noted by WLRN, the Texas-based company Othram reported in April 2026 that its technology helped solve at least 600 cold cases across the country. Such advancements are vital for establishing kinship, identifying human remains, and connecting suspects to crime locations, ultimately strengthening law enforcement worldwide. At the same time, rising government support and financial backing for forensic science play a critical role in building the market's infrastructure and operational scale. Authorities around the world increasingly acknowledge the importance of advanced DNA testing for public safety and crime solving, prompting direct investments in specialized training, technology integration, and database growth. These efforts primarily aim to shrink forensic case backlogs and improve tools for intricate investigations. For instance, WLRN reported in April 2026 that the Florida Attorney General unveiled a $600,000 collaboration with a firm focused on linking cold case DNA to genetic genealogy networks. This financial dedication aids in procuring genomic hardware and fostering global partnerships. Additionally, Othram highlighted in December 2025 that a comprehensive review of 477 human remains cases in North America resulted in successful identifications, emphasizing the wide-ranging benefits of forensic genomics fueled by these investments.

Market Challenge

The massive financial investment needed for cutting-edge genomic technologies acts as a major roadblock to the growth of the global forensic genomics market. This hurdle includes the steep expenses tied to acquiring the intricate bioinformatics software, specialized reagents, and advanced machinery required for contemporary DNA testing. Such heavy financial burdens create a significant obstacle for many forensic facilities, especially those functioning on tight budgets or located in developing nations. Consequently, these high upfront costs directly impede the widespread acceptance and practical use of modern genomic practices. Facilities facing financial constraints frequently find it difficult to purchase necessary equipment and cover continuous operational costs, such as software licenses and daily consumables. This predicament limits their capacity to adopt new genomic methods or modernize their current systems, ultimately hindering broader market progress. To illustrate, the Consortium of Forensic Science Organizations (CFSO) noted in its July 2024 budget brief for Fiscal Year 2025 that the U.S. House of Representatives suggested a minimum of $2,000,000 for high-density sequencing out of the $6,000,000 designated for the National Missing and Unidentified Persons System (NamUs). This restricted funding underscores the budgetary constraints experienced by numerous regions, directly affecting the broad utilization of accurate genomic resources in legal and criminal inquiries.

Market Trends

The extensive implementation of Next-Generation Sequencing (NGS) in everyday casework is profoundly altering what forensic laboratories can achieve. This transition facilitates a more thorough and intricate genetic evaluation for regular criminal cases, surpassing older, lower-resolution techniques. NGS permits the concurrent examination of a vastly greater array of genetic markers, yielding deeper investigative insights even from difficult or trace DNA evidence. As an example, Syracuse University reported in June 2025 in 'Setting the Standard, Ensuring Justice' that the Kern Regional Crime Lab effectively employed NGS to assess more than 150 genetic markers from one murder investigation evidence sample, a massive leap from the roughly 24 markers identified by previous methods. At the same time, merging artificial intelligence (AI) with bioinformatics for automated data reading is becoming a prominent trend, helping labs manage the surging volume and intricacy of genomic information. Tools driven by AI simplify the tedious data analysis workflow, boost precision in separating DNA mixtures, and minimize the risk of human mistakes when deciphering complicated profiles. Such automation is essential for increasing laboratory productivity and speeding up the closure of cases. Highlighting this shift, Research.com noted in April 2026 through '2026 AI, Automation, and the Future of Forensic Science Degree Careers' that 35% of forensic science facilities in the United States have already started integrating AI-based technologies into their daily operations.

Key Market Players

• Illumina, Inc.
• Verogen, Inc.
• Agilent Technologies, Inc.
• Thermo Fischer Scientific, Inc.
• QIAGEN N.V.
• GE Healthcare
• Gene by Gene, Ltd.
• Neogen Corporation
• Eurofins Scientific SE
• Othram Inc.

Report Scope

In this report, the Global Forensic Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Forensic Genomics Market, By Component

• Kits
• Analyzers & Sequencers
• Software
• Consumables

Forensic Genomics Market, By Technique

• Capillary Electrophoresis {CE}
• Next-generation Sequencing {NGS}
• PCR Amplification

Forensic Genomics Market, By Application

• Criminal Testing
• Paternity & Familial Testing
• Biodefense
• Others

Forensic Genomics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Forensic Genomics Market.

Available Customizations:

Global Forensic Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Forensic Genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Kits, Analyzers & Sequencers, Software, Consumables)
  • 5.2.2. By Technique (Capillary Electrophoresis {CE}, Next-generation Sequencing {NGS}, PCR Amplification)
  • 5.2.3. By Application (Criminal Testing, Paternity & Familial Testing, Biodefense, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Forensic Genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Forensic Genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Forensic Genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Forensic Genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application

7. Europe Forensic Genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Forensic Genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
  • 7.3.2. France Forensic Genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Forensic Genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Forensic Genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Forensic Genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application

8. Asia Pacific Forensic Genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Forensic Genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
  • 8.3.2. India Forensic Genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Forensic Genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Forensic Genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Forensic Genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application

9. Middle East & Africa Forensic Genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Forensic Genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Forensic Genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Forensic Genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application

10. South America Forensic Genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Forensic Genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Forensic Genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Forensic Genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Forensic Genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Verogen, Inc.
• 15.3. Agilent Technologies, Inc.
• 15.4. Thermo Fischer Scientific, Inc.
• 15.5. QIAGEN N.V.
• 15.6. GE Healthcare
• 15.7. Gene by Gene, Ltd.
• 15.8. Neogen Corporation
• 15.9. Eurofins Scientific SE
• 15.10. Othram Inc.

16. Strategic Recommendations

17. About Us & Disclaimer